Northwestern University

Researchers

• AAAtique U Ahmed

Running trials

• Not yet recruiting

  Preoperative Durvalumab, Cisplatin, Gemcitabine With or Without Futibatinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, OPTIC Trial

  NCT07639528· Phase 2· Northwestern University· Source

• Not yet recruiting

  Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

  NCT07594548· Phase 1· Northwestern University· Source

• Not yet recruiting

  Enfortumab Vedotin for the Treatment of Unresectable or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer, Anaplastic Thyroid Cancer, Medullary Thyroid Cancer, or NUT Carcinoma

  NCT07863765· Phase 2· Northwestern University· Source

• Not yet recruiting

  A MOST Framework Trial Evaluating the MOst effectiVe Exercise Types for Blood Pressure Control

  NCT07915752· Northwestern University· Source

• Not yet recruiting

  Using an Artificial Intelligence Software Tool (iSeg) During Radiation Treatment Planning for Patients With Lung Tumors

  NCT07898241· Northwestern University· Source

• Not yet recruiting

  The AYA Oncology Self-care Movement

  NCT07724652· Northwestern University· Source

• Not yet recruiting

  Fit2ThriveMB: Optimization of a Physical Activity Promotion Intervention for Metastatic Breast Cancer Patients

  NCT07840599· Northwestern University· Source

• Not yet recruiting

  A Phase I First-in-human Trial of Bvax (B-cell Vaccination) in Addition to Standard of Care Chemoradiotherapy for Newly Diagnosed Glioblastoma

  NCT07422896· Phase 1· Catalina Lee Chang· Source

• Not yet recruiting

  Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis

  NCT07674745· Phase 2· University of Alabama at Birmingham· Source

• Not yet recruiting

  COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"

  NCT07281027· Phase 3· Yale University· Source

• Recruiting

  Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)

  NCT07665372· Johns Hopkins University· Source

• Not yet recruiting

  A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer

  NCT07349641· Phase 2· National Cancer Institute (NCI)· Source

• Not yet recruiting

  A Study of LY3873862 in Participants With Sporadic or Familial Amyotrophic Lateral Sclerosis (ALS).

  NCT07883590· Phase 1· Eli Lilly and Company· Source

• Recruiting

  SMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC Trial

  NCT07748611· Phase 2· Northwestern University· Source

• Not yet recruiting

  Testing the SurVaxM Vaccine for Lung Cancer Prevention

  NCT07169617· Phase 2· National Cancer Institute (NCI)· Source

• Not yet recruiting

  Gestational Hypertension and Preeclampsia Blood Pressure (BP) Treatment Goals Less Than 140/90 vs. Less Than 160/110 mmHg: The GOALPOST Trial

  NCT07746271· Phase 3· The George Washington University Biostatistics Center· Source

• Recruiting

  Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

  NCT06917911· Phase 2· National Cancer Institute (NCI)· Source

• Not yet recruiting

  Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis

  NCT07520110· Phase 3· University of Massachusetts, Worcester· Source

• Not yet recruiting

  Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With Down Syndrome

  NCT07469176· Northwestern University· Source

• Enrolling by invitation

  The BANYAN Trial, an ALS MyMatch Trial Evaluating Safety, Biomarker Activity, and Microglial Activation of Nasal Foralumab

  NCT07688239· Phase 2· Tiziana Life Sciences LTD· Source

• Not yet recruiting

  Stroke Training to Advance Balance During Locomotor Experiences (STABLE) Trial

  NCT07802470· Northwestern University· Source

• Recruiting

  Healey ALS MyMatch Common Screening Protocol

  NCT07400393· Massachusetts General Hospital· Source

• Recruiting

  A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy

  NCT07771465· Phase 3· Kardigan, Inc.· Source

• Recruiting

  BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion

  NCT07594626· Phase 1/2· Northwestern University· Source

• Recruiting

  Parents and Babies Pilot

  NCT07607613· Northwestern University· Source

• Recruiting

  Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Advanced Head and Neck Cancer Who Cannot Receive Cisplatin

  NCT07441681· Phase 3· NRG Oncology· Source

• Recruiting

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  Genicular Artery Embolization for Knee Osteoarthritis

  NCT07537153· Northwestern University· Source

• Recruiting

  Pridopidine Phase 3 Study in Huntington's Disease

  NCT07609108· Phase 3· Prilenia· Source

• Recruiting

  A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain

  NCT07641517· Phase 2· Eli Lilly and Company· Source

• Recruiting

  The REACH-OUT Trial

  NCT07540143· Northwestern University· Source

• Recruiting

  A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  NCT07595549· Phase 3· Pfizer· Source

• Recruiting

  MINT Conditioning to Improve Gait

  NCT07041775· Northwestern University· Source

• Recruiting

  A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

  NCT07428616· Phase 2· Exelixis· Source

• Recruiting

  Defining the Ablative Dose for Y-90 TARE

  NCT07586046· Phase 2· Northwestern University· Source

• Recruiting

  PREACTIVE: Preconditioning Exercise Intervention to Improve Symptoms and Quality of Life in Comorbid Atrial Fibrillation and HFpEF

  NCT07324772· Northwestern University· Source

• Recruiting

  Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

  NCT07579702· Insulet Corporation· Source

• Recruiting

  Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

  NCT07296744· Supira Medical· Source

• Recruiting

  Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

  NCT07521475· Insulet Corporation· Source

• Recruiting

  Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

  NCT07321652· Phase 3· Alliance for Clinical Trials in Oncology· Source

• Recruiting

  Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis

  NCT07230964· Dermed Diagnostics, Inc.· Source

• Recruiting

  Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies

  NCT07427017· Phase 2· Northwestern University· Source

• Recruiting

  Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

  NCT07195734· Phase 2· National Cancer Institute (NCI)· Source

• Recruiting

  A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

  NCT07285655· Phase 3· Liquidia Technologies, Inc.· Source

• Recruiting

  Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

  NCT07068074· Phase 3· ECOG-ACRIN Cancer Research Group· Source

• Recruiting

  A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

  NCT06769698· Phase 2· Regeneron Pharmaceuticals· Source

• Recruiting

  N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy

  NCT07261657· Early phase 1· Seth Pollack· Source

• Recruiting

  Experimental Evidence of the Impact of Parental Income on Child Mental Health and Neuroimmune Function

  NCT07641244· Northwestern University· Source

• Recruiting

  Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

  NCT07200830· Phase 3· Alliance for Clinical Trials in Oncology· Source

• Recruiting

  Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer

  NCT07042919· Phase 1/2· Devalingam Mahalingam· Source

Showing 50 of 603.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer22 recruiting
• Prostate cancer13 recruiting
• High blood pressure10 recruiting
• Stroke10 recruiting
• ALS (motor neurone disease)9 recruiting
• Childhood cancers9 recruiting
• Head and neck cancer9 recruiting
• Pancreatic cancer9 recruiting
• Acute myeloid leukaemia8 recruiting
• Bladder cancer8 recruiting
• Gastric and oesophageal cancer8 recruiting
• Heart failure8 recruiting
• Chronic lymphocytic leukaemia7 recruiting
• Endometrial cancer6 recruiting
• Metastatic breast cancer6 recruiting
• Ovarian cancer6 recruiting
• Sarcoma6 recruiting
• Alzheimer disease5 recruiting
• Colorectal cancer5 recruiting
• Cystic fibrosis5 recruiting
• Hearing loss5 recruiting
• Liver and biliary tract cancer5 recruiting
• Neuroendocrine tumours5 recruiting
• Type 1 diabetes5 recruiting
• Type 2 diabetes5 recruiting
• Atrial fibrillation4 recruiting
• Coronary artery disease4 recruiting
• Epilepsy4 recruiting
• Glioblastoma4 recruiting
• Kidney cancer4 recruiting
• Liver cirrhosis4 recruiting
• Melanoma4 recruiting
• Myelodysplastic syndromes4 recruiting
• Osteoarthritis4 recruiting
• Pulmonary arterial hypertension4 recruiting
• Ulcerative colitis4 recruiting
• Acute lymphoblastic leukaemia3 recruiting
• Chronic kidney disease3 recruiting
• COPD3 recruiting
• Diffuse large B-cell lymphoma3 recruiting
• Frontotemporal dementia3 recruiting
• HIV3 recruiting
• Idiopathic pulmonary fibrosis3 recruiting
• Mild cognitive impairment3 recruiting
• Myeloproliferative neoplasms3 recruiting
• Obesity3 recruiting
• Parkinson disease3 recruiting
• Thyroid cancer3 recruiting
• Triple-negative breast cancer3 recruiting
• Amyloidosis2 recruiting
• Crohn's disease2 recruiting
• Dilated cardiomyopathy2 recruiting
• Eosinophilic oesophagitis2 recruiting
• Follicular lymphoma2 recruiting
• Gestational diabetes2 recruiting
• Giant cell arteritis2 recruiting
• Huntington's disease2 recruiting
• Meningioma2 recruiting
• Peripheral artery disease2 recruiting
• Rheumatoid arthritis2 recruiting
• Alopecia areata1 recruiting
• ANCA-associated vasculitis1 recruiting
• Aortic stenosis1 recruiting
• Atopic dermatitis (eczema)1 recruiting
• Barrett's oesophagus1 recruiting
• Brain metastases1 recruiting
• Cervical cancer1 recruiting
• Depression1 recruiting
• Down syndrome1 recruiting
• Duchenne muscular dystrophy1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Gastroparesis1 recruiting
• Hepatitis B1 recruiting
• Hidradenitis suppurativa1 recruiting
• Hypertrophic cardiomyopathy1 recruiting
• IgA nephropathy1 recruiting
• Insomnia1 recruiting
• Mantle cell lymphoma1 recruiting
• Mesothelioma1 recruiting
• Multiple myeloma1 recruiting
• Multiple sclerosis1 recruiting
• Optic neuritis1 recruiting
• Primary biliary cholangitis1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting
• Tuberculosis1 recruiting
• Vascular dementia1 recruiting
• Vitiligo1 recruiting

Closed trials

• Withdrawn

  Implementation of AIP Services for Older Adults With AD

  NCT07361601· Northwestern University· Source

• Completed

  SAGE LEAF 2: An Online Program to Reduce Dementia Caregiver Burden

  NCT06708182· Northwestern University· Source

• Recruiting

  Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis

  NCT06978660· Idoven 1903 S.L.· Source

• Completed

  NE3107 in Adults With Neurological Symptoms of Long COVID

  NCT06847191· Phase 2· BioVie Inc.· Source

• Completed

  A Digital Therapeutic Platform for Swallowing and Drooling Problems in Parkinson's

  NCT04664634· Phase 3· Northwestern University· Source

• Completed

  Omnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 Diabetes

  NCT06865989· Insulet Corporation· Source

• Completed

  GYNecologic Cancer-Related COGnitive Impairment

  NCT06662435· Northwestern University· Source

• Completed

  Point-of-Care Echocardiography in Patients With Known or Suspected Aortic Stenosis

  NCT06717373· Caption Health, Inc.· Source

• Completed

  REVEAL - Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis

  NCT06788535· Phase 3· Sharmila Dorbala· Source

• Terminated

  Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial)

  NCT05554354· Phase 2· National Cancer Institute (NCI)· Source

• Completed

  Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers

  NCT06667414· Hoffmann-La Roche· Source

• Recruiting

  A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

  NCT06319820· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  Platform Clinical Study for Conquering Scleroderma

  NCT06195072· Phase 2· Scleroderma Research Foundation, Inc.· Source

• Withdrawn

  Venetoclax, Rituximab and Nivolumab in Combination for the Treatment of Richter's Transformation Arising From Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

  NCT06247540· Phase 2· Northwestern University· Source

• Completed

  Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

  NCT06273124· Tandem Diabetes Care, Inc.· Source

• Completed

  Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors

  NCT06169124· Phase 2· National Cancer Institute (NCI)· Source

• Completed

  SafeHeal Diverting Ileostomy Pivotal Study

  NCT06152276· SafeHeal Inc· Source

• Completed

  Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma

  NCT06058793· Phase 3· Boehringer Ingelheim· Source

• Completed

  An Electronic Health Record-based Approach to Increase PrEP Knowledge and Uptake: the EMC2 PrEP Strategy

  NCT05709860· Northwestern University· Source

• Completed

  The PEERLESS II Study

  NCT06055920· Inari Medical· Source

• Completed

  An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)

  NCT06021054· Phase 3· Viridian Therapeutics, Inc.· Source

• Withdrawn

  Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abiraterone

  NCT06060587· Phase 2· Northwestern University· Source

• Recruiting

  Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples

  NCT06071845· Mayo Clinic· Source

• Completed

  A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

  NCT06074562· Phase 2· Eli Lilly and Company· Source

• Terminated

  Tomivosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML)

  NCT05744739· Phase 1· Northwestern University· Source

• Completed

  Individually-guided Hearing Aid Fitting

  NCT03345654· Northwestern University· Source

• Completed

  Walking Balance Training Post-Stroke

  NCT06090604· Northwestern University· Source

• Completed

  Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection

  NCT05776225· United Therapeutics· Source

• Completed

  A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee

  NCT05931367· Phase 3· Eli Lilly and Company· Source

• Completed

  A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight

  NCT05929066· Phase 3· Eli Lilly and Company· Source

• Completed

  Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM

  NCT05767346· Phase 3· Cytokinetics· Source

• Withdrawn

  PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer

  NCT04910425· Phase 2· Northwestern University· Source

• Completed

  Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis

  NCT05908240· University of Pennsylvania· Source

• Completed

  A Study of CDX-0159 in Patients With Eosinophilic Esophagitis

  NCT05774184· Phase 2· Celldex Therapeutics· Source

• Completed

  A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

  NCT05785832· Tandem Diabetes Care, Inc.· Source

• Completed

  A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

  NCT05882045· Phase 3· Eli Lilly and Company· Source

• Completed

  Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis

  NCT05671835· Phase 2· Tvardi Therapeutics, Incorporated· Source

• Terminated

  ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers

  NCT05616624· Phase 1/2· Washington University School of Medicine· Source

• Completed

  Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD

  NCT05819359· Phase 2· Bial R&D Investments, S.A.· Source

• Completed

  Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion

  NCT05477147· Volta Medical· Source

• Completed

  Narcolepsy Nightmare Study

  NCT05709873· Northwestern University· Source

• Completed

  Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate

  NCT05605964· Phase 3· Sumitomo Pharma America, Inc.· Source

• Completed

  AESOPS Trial 2 (AESOPS-2): Availability of Opioid Harm

  NCT04758637· University of Southern California· Source

• Completed

  A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).

  NCT05578872· Phase 1/2· Anaveon AG· Source

• Completed

  A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

  NCT05271604· Phase 2· BioAtla, Inc.· Source

• Completed

  Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)

  NCT05291091· Phase 2· Edgewise Therapeutics, Inc.· Source

• Recruiting

  Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

  NCT05363280· Phase 2· Advenchen Pharmaceuticals, LLC.· Source

• Completed

  Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF

  NCT05284617· Phase 2· Rivus Pharmaceuticals, Inc.· Source

• Completed

  Direct-to-Consumer Hearing Aids and Listening Effort

  NCT05855005· Northwestern University· Source

• Terminated

  Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory

  NCT05576896· Phase 2· Northwestern University· Source

Showing 50 of 195.

Conditions

Diseases this institution publishes on or runs trials for.

• Heart failure289 works · 20 trials
• Stroke259 works · 16 trials
• HIV252 works · 9 trials
• Obesity193 works · 14 trials
• Alzheimer disease172 works · 13 trials
• Glioblastoma124 works · 14 trials
• Parkinson disease121 works · 12 trials
• Prostate cancer119 works · 47 trials
• Lung cancer116 works · 76 trials
• Atopic dermatitis (eczema)104 works · 4 trials
• Atrial fibrillation101 works · 12 trials
• Asthma98 works · 1 trial
• Type 2 diabetes89 works · 12 trials
• Epilepsy83 works · 5 trials
• Melanoma73 works · 35 trials
• Chronic kidney disease69 works · 7 trials
• Spinal cord injury67 works · 0 trials
• Deep vein thrombosis and pulmonary embolism53 works · 6 trials
• Sarcoma50 works · 28 trials
• Osteoarthritis48 works · 14 trials
• Congenital heart disease46 works · 0 trials
• Meningioma45 works · 6 trials
• Multiple sclerosis43 works · 4 trials
• Chronic rhinosinusitis with nasal polyps42 works · 0 trials
• Gestational diabetes40 works · 3 trials
• Psoriasis37 works · 3 trials
• Ovarian cancer36 works · 28 trials
• Ulcerative colitis35 works · 9 trials
• Hearing loss33 works · 7 trials
• Pancreatic cancer33 works · 28 trials